Author:
Saroya Amritpal Singh,Singh Jaswinder
Reference95 articles.
1. Bach-Rojecky L, Kalodjera Z, Samarzija I. The antidepressant activity of Hypericum perforatum L. measured by two experimental methods on mice. Acta Pharma. 2004;54:157–62.
2. Baureithel KH, Berger Buter K, Engesser A, Bukard W, Schaffner W. Inhibition of benzodiazepine binding in vitro by amentoflavone, a constituent of various species of Hypericum. Pharm Act Helvetiae. 1997;72:153–7.
3. Beijamini V, Andreatini R. Effects of Hypericum perforatum and paroxetine on rat performance in the elevated T-maze. Pharmacol Res. 2003;48:199–207.
4. Berghoefer R, Hoelzl J. Bioflavonoids in Hypericum perforatum. Part 1. Isolation of 13, II8- biapigenin. Planta Med. 1987;53:216–7.
5. Bladt S, Wagner H. Inhibition of MAO by fractions and constituents of Hypericum extract. J Geriatr Psychiatry Neurol. 1994;7:57–9.